We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

92 hedge funds and large institutions have $255M invested in Dianthus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

17% more capital invested

Capital invested by funds: $217M → $255M (+$37.9M)

0.07% more ownership

Funds ownership: 4.14% → 4.21% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2% less funds holding

Funds holding: 94 → 92 (-2)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

72% less call options, than puts

Call options by funds: $46K | Put options by funds: $164K

Holders
92
Holders Change
-2
Holders Change %
-2.13%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
35
Reduced
25
Closed
8
Calls
$46K
Puts
$164K
Net Calls
-$118K
Net Calls Change
-$32K

Top Buyers

1
ACM
Aquilo Capital Management
California
+$9.27M
2
JP Morgan Chase
JP Morgan Chase
New York
+$1.51M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.13M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$960K
5
PIM
Platinum Investment Management
Australia
+$834K

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$9.63M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.05M
3
PM
Prosight Management
Texas
-$840K
4
Squarepoint
Squarepoint
New York
-$376K
5
UBS AM
UBS AM
Illinois
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.13M +$108K +949 +12%
Truist Financial
27
Truist Financial
North Carolina
$1.04M +$21.2K +187 +2%
PM
28
Prosight Management
Texas
$985K -$840K -7,413 -49%
Citadel Advisors
29
Citadel Advisors
Florida
$789K +$185K +1,634 +35%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$764K – – –
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$743K +$134K +1,181 +25%
AA
32
ALPS Advisors
Colorado
$684K +$182K +1,605 +42%
Russell Investments Group
33
Russell Investments Group
United Kingdom
$614K -$79.4K -700 -12%
Goldman Sachs
34
Goldman Sachs
New York
$608K -$118K -1,043 -18%
Marshall Wace
35
Marshall Wace
United Kingdom
$572K – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$531K +$15.6K +138 +3%
Millennium Management
37
Millennium Management
New York
$511K +$197K +1,739 +75%
CS
38
Credit Suisse
Switzerland
$455K +$21.7K +191 +6%
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
$433K -$84.2K -743 -18%
Charles Schwab
40
Charles Schwab
California
$399K – – –
OM
41
Opaleye Management
Massachusetts
$375K +$339K +2,988 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$305K – – –
Barclays
43
Barclays
United Kingdom
$304K +$30.3K +267 +12%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$292K -$6.35K -56 -2%
AG
45
Algert Global
California
$291K -$70K -617 -21%
PP
46
PDT Partners
New York
$256K +$231K +2,037 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$246K – – –
FT
48
Fiduciary Trust
Massachusetts
$235K – – –
BG
49
Bollard Group
Massachusetts
$220K – – –
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$206K -$23.4K -206 -11%
1
2
3 4

DNTH Hedge Fund Activity: Q4 2020 in Review

92 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q4 2020, worth a combined $255M — up 17% from $217M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of DNTH and 7 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 35 added.

The largest buyer was Aquilo Capital Management, adding an estimated $9.27M. The largest seller was Eventide Asset Management, cutting an estimated $9.63M.

  • 92 institutional investors held Dianthus Therapeutics (DNTH) as of Q4 2020, down from 94 in Q3 2020.
  • Funds reported $255M of Dianthus Therapeutics stock for Q4 2020, up 17% quarter-over-quarter.
  • 7 funds opened new Dianthus Therapeutics positions in Q4 2020 and 8 closed out, a net change of -1 holder.
  • The largest Dianthus Therapeutics buyer in Q4 2020 was Aquilo Capital Management, an estimated $9.27M added.
  • The largest Dianthus Therapeutics seller in Q4 2020 was Eventide Asset Management, an estimated $9.63M sold.

Based on aggregated 13F filings for Q4 2020.